Spyre Therapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

36,179

Value ($000)

16

Weight

0.0%

2020 Q1 - 2023 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	16	0.0%	36,179	6/30/2023
2022 Q4	2/14/2023	23	0.0%	50,943	12/31/2022
2022 Q2	8/15/2022	33	0.0%	65,195	6/30/2022
2021 Q3	11/15/2021	89	0.0%	11,192	9/30/2021
2020 Q4	2/16/2021	84	0.0%	10,661	12/31/2020
2020 Q3	11/16/2020	80	0.0%	11,218	9/30/2020
2020 Q1	5/15/2020	70	0.0%	15,022	3/31/2020